New Blood Test May Help Predict Recurrence and Survival in Head and Neck Cancer Patients
Researchers at Mass General Brigham have developed a promising blood test that could help physicians identify head and neck cancer patients at higher risk of disease recurrence and poorer survival outcomes, potentially enabling more personalized treatment strategies and follow-up care.












